// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

PATTERNS OF DISEASE ACTIVITY IMPACT ON ORGAN DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS

A. Bortoluzzi - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

PREGNANCY IN SLE: STILL CHALLENGING FETAL AND MATERNAL ISSUES

R. Fischer-Betz - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

REMISSION INDUCTION WITH METHOTREXATE STEP-UP THERAPY VERSUS COMBINATION OF HYDROXYCHLOROQUINE, METHOTREXATE AND TRIAMCINOLONE: 3 YEAR RESULTS

T. Brunekreef - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

TARGETED MEDICINE: THERAPEUTIC USE OF FUNCTIONAL CYTOKINE ASSAYS IN COMPLEX INFLAMMATORY ARTHRITIS

E.E.P. Htut - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE ON SOLUBLE TISSUE FACTOR LEVELS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND ANTIPHOSPHOLIPID SYNDROME WITH AND WITHOUT UNDERLYING SYSTEMIC LUPUS ERYTHEMATOSUS

K. Schreiber - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

TOLERABILITY, EFFICACY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS

G.M. Tarasova - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

WHICH DRUGS IN PREGNANT PATIENTS?

M. Ostensen - European League Against Rheumatism (EULAR) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

Modulation of autophagy: A phase II study of vorinostat (VOR) plus hydroxychloroquine (HCQ) vs regorafenib (RGF) in chemo-refractory metastatic colorectal cancer (mCRC).

Sukeshi Patel Arora - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydroxychloroquine

Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Finalanalysis of phase II, open label, randomized, multicenter trial.

Libor Havel - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydroxychloroquine

Phase I trial of chloroquine (CQ)/hydroxychloroquine (HCQ) in combination with carboplatin-gemcitabine (CG)in patients with advanced solid tumors.

Nagla Fawzy Abdel Karim - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Hydroxychloroquine

Radiomic profiles via machine learning to predict response, overall survival, and KRAS status in metastatic colorectal tumors treated with FOLFOX/bevacizumab/hydroxychloroquine.

Saima Rathore - American Society of Clinical Oncology (ASCO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Amyloid (SAA) Arthropathy in Chronic Rheumatoid Arthritis: A Case Report

Jacob Karsh - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non-Hodgkin's Lymphoma

Hydroxychloroquine

Efficacy of Methotrexate Monotherapy Compared to Combination Therapy with Methotrexate and Hydroxychloroquine in the Treatment of Early Rheumatoid Arthritis after 12 Months of Treatment.

Tharindri Dissanayake - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Early inflammatory arthritis

Hydroxychloroquine

Rat Bite Fever Resembling Rheumatoid Arthritis in a 46 Year Old Female

Paul Boland - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Rheumatoid arthritis

Hydroxychloroquine

Anti-Ro Antibodies and Cancer in Systemic Lupus Erythematosus

Ann Clarke - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Hypereosinophilia and Stroke as First Presentation of SLE

Aurore Fifi-Mah - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Eosinophilic granulomatosis with polyangiitis

Hydroxychloroquine

Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus

Dafna Gladman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lupus

Hydroxychloroquine

Recurrent Benign Pneumatosis Intestinalis in a Patient with Systemic Sclerosis

Sahil Koppikar - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Non-Ischemic cardiomyopathy

Hydroxychloroquine

The Use of IVIG in a Complicated Case of Rheumatoid Arthritis

Aurore Fifi-Mah - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Congestive heart failure

Hydroxychloroquine

Hydroxychloroquine-induced Cardiomyopathy Presenting as Heart Failure

Gina Rohekar - Canadian Rheumatology Association (CRA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Left ventricular hypertrophy

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved